Skip to main content
SpringerLink
Log in

Effects of naloxone infusion on nocturnal prolactin secretion and Fos/FRA expression in pregnant rats

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Dopamine (DA) secreted by tubero infundibular dopaminergic (TIDA) neurons in the hypothalamus is the major inhibitory factor controlling prolactin (PRL) secretion from the anterior pituitary. Endogenous opioid peptides (EOPs), mainly the neuropeptide β-endorphin, have a stimulatory influence on PRL secretion. During the first half of pregnancy in rats, PRL secretion is characterized by two daily surges, the nocturnal surge and the diurnal surge. We tested the hypothesis that EOPs are critical stimulatory factors in regulating the nocturnal PRL surge, possibly via inhibition of TIDA neuronal activity. Naloxone (NAL), an opioid antagonist, was continuously infused (0.2 mg/10 μL/min iv) during the expected time of the nocturnal PRL surge in day 8 pregnant rats. Radioimmunoassay (RIA) was used to measure plasma PRL levels, and the immunocytochemical (ICC) staining of Fos/FRA was performed to detect changes in transcriptional activity of neurons in the hypothalamus. ICC of tyrosine hydroxylase (TH), the rate-limiting enzyme for DA synthesis, was performed to visualize TIDA neurons in the arcuate nucleus. The results showed that the nocturnal surge of PRL was markedly delayed and dampened in NAL-treated rats (p<0.01). The numbers of both Fos/FRA and (Fos/FRA)/TH dual-staining neurons increased in the arcuate nucleus following NAL treatment (p<0.05 for both comparisons).

These data indicate that EOPs are critical stimulatory factors for the nocturnal PRL surge and that the actions of EOPs are partially mediated via decreasing TIDA neuronal activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Butcher, R. L., Fugo, N. W., and Collins, W. E. (1972) Endocrinology 90, 1125–1127.

    PubMed  CAS  Google Scholar 

  2. Gala, R. R. and Haisenleder, D. J. (1984) Life Sci. 34, 179–185.

    Article  PubMed  CAS  Google Scholar 

  3. Morishige, W. K. and Rothchild, I. (1974) Endocrinology 95, 260–274.

    PubMed  CAS  Google Scholar 

  4. Ben-Jonathan, N. (1985) Endocr. Reviews 6(4), 564–589.

    Article  CAS  Google Scholar 

  5. Bjorklund, A., Moore, R. Y., Nobin, A., and Stenevi, U. (1973) Brain Res. 51, 171–191.

    Article  PubMed  CAS  Google Scholar 

  6. Rivier, C., Vale, W., Ling, N., Brown, M., and Guillemin, R. (1977) Endocrinology 100, 238–241.

    PubMed  CAS  Google Scholar 

  7. Ferland, L., Kledzik, G. S., Cusan, L., and Labrie, F. (1978) Mol. Cell Endocrinology 12, 267–272.

    Article  CAS  Google Scholar 

  8. Ieiri, T., Chen, H. T., Campbell, G. A., and Meites, J. (1980) Endocrinology 106, 1568–1570.

    Article  PubMed  CAS  Google Scholar 

  9. Callahan, P., Baumann, M. H. and Rabii, J. (1996) J. Neuroendocrinology 8, 771–776.

    Article  CAS  Google Scholar 

  10. Selmanoff, M. and Gregerson, K. A. (1986) Neuroendocrinology 42, 255–259.

    PubMed  CAS  Google Scholar 

  11. Brown, B., Deffmar, P. W., Dobson, P. R., Lynn, A. G., Metcalf, G., and Morgan B. A. (1978) J. Pharm. Pharmacol. 30, 644–645.

    PubMed  CAS  Google Scholar 

  12. Mezey, E., Kiss, J. Z., Mueller, G. P., Eskay, R., O'Donohue, T. L., and Palkovits, M. (1985) Brain Res. 328, 341–347.

    Article  PubMed  CAS  Google Scholar 

  13. Moore, K. E. and Lookingland, K. J. (1995) In: Psychopharmacology: The Fifth Generation of Progress. Bloom, F. E., Kupfer, D. J. (eds.), Raven Press, New York.

    Google Scholar 

  14. Horvath, T. L., Naftolin, F., and Leranth, C. (1992) Endocrinology 131(3), 1547–1555.

    Article  PubMed  CAS  Google Scholar 

  15. Morel, G. and Pelletier, G. (1986) Peptides 7, 1197–1199.

    Article  PubMed  CAS  Google Scholar 

  16. Mansour, A., Fox, C. A., Akil, H., and Watson, S. J. (1995) Trends Neurosci. 18, 22–29.

    Article  PubMed  CAS  Google Scholar 

  17. Van Loon, G. R., Ho, D., and Kim, C. (1980) Endocrinology 106, 76–80.

    PubMed  Google Scholar 

  18. Gudelsky, G. A. and Porter, J. C. (1979) Life Sci. 25, 1697–1702.

    Article  PubMed  CAS  Google Scholar 

  19. Arita, J. and Kimura, F. (1988) Endocrinology 123, 694–699.

    PubMed  CAS  Google Scholar 

  20. Sagrillo, C. A. and Voogt, J. L. (1991) Endocrinology 129(2), 925–930.

    Article  PubMed  CAS  Google Scholar 

  21. Wang, H. J., Hoffman, G. E., and Smith, M. S. (1993) Endocrinology 133(4), 1657–1663.

    Article  PubMed  CAS  Google Scholar 

  22. Pape, J. R., Hiofi, P., and Tramu, G. (1996) J. Neuroendocrinology 8, 375–386.

    Article  CAS  Google Scholar 

  23. Erskine, M. S. (1995) Endocrine Review 16(4), 508–528.

    Article  CAS  Google Scholar 

  24. Neill, J. D. and Nagy, G. M. (1994) In: The Physiology of Reproduction. 2nd ed. Knobil, E. and Neill, J. D. (eds.), Raven Press, New York.

    Google Scholar 

  25. Janik, J., Callahan, P., and Rabii, J. (1996) J. Neuroendocrinology 4(6), 701–708.

    Article  Google Scholar 

  26. James, I. F. and Goldstein, A. (1984) Mol. Pharmacol. 25, 337–342.

    PubMed  CAS  Google Scholar 

  27. Vale, W., Rivier, C., and Brown, M. (1977) Annu. Rev. Physiol. 39, 473.

    Article  PubMed  CAS  Google Scholar 

  28. Arey, B. J. and Freeman, M. E. (1990) Endocrinology 126, 279–284.

    PubMed  CAS  Google Scholar 

  29. Arey, B. J. and Freeman, M. E. (1990) Endocrinology 130(1), 126–132.

    Article  Google Scholar 

  30. Fitzsimmons, M. D., Olschowka, J. A., Wiegand, S. J., and Hoffman, G. E. (1992) Brain Res. 581, 10–18.

    Article  PubMed  CAS  Google Scholar 

  31. Paxinos, G. and Watson, G. (eds.) (1997) In: The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.

    Google Scholar 

  32. Lerant, A., Herman, M. E., and Freeman, M. E. (1996) Endocrinology 137(9), 3621–3628.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Integrative Physiology, University of Kansas Medical Center, 66160, Kansas City, KS

    Yueping Hou & James L. Voogt

Authors
  1. Yueping Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James L. Voogt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James L. Voogt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hou, Y., Voogt, J.L. Effects of naloxone infusion on nocturnal prolactin secretion and Fos/FRA expression in pregnant rats. Endocr 10, 145–152 (1999). https://doi.org/10.1385/ENDO:10:2:145

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:10:2:145

Key words

Search

Navigation